REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Novoduginskaya Apteka (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Novoduginskaya Apteka Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

MUP Novoduginskaya Apteka is an enterprise based in Russia. Its main office is in Smolensk Oblast. It operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on August 06, 2003. It currently has a total number of 18 (2009) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 1.28% in 2023. Its’ total assets recorded a growth of 12.79%. The net profit margin of MUP Novoduginskaya Apteka increased by 0.85% in 2023.

Headquarters
Novodugino, Moiseenko, 5
Smolensk Oblast; Smolensk Oblast; Postal Code: 215240

Contact Details: Purchase the MUP Novoduginskaya Apteka report to view the information.

Basic Information
Total Employees:
Purchase the MUP Novoduginskaya Apteka report to view the information.
Outstanding Shares:
Purchase the MUP Novoduginskaya Apteka report to view the information.
Registered Capital:
Purchase the MUP Novoduginskaya Apteka report to view the information.
Incorporation Date:
August 06, 2003
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MUP Novoduginskaya Apteka report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
1.28%
Total operating revenue
1.28%
Operating profit (EBIT)
271.43%
Net Profit (Loss) for the Period
271.43%
Total assets
12.79%
Total equity
12.79%
Operating Profit Margin (ROS)
0.85%
Net Profit Margin
0.85%
Return on Equity (ROE)
4.78%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?